Preisler, H D <br/><br/>
Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.  [electronic resource] 

 -  Cancer treatment and research  2001 
 - 185-230 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review 
<br/><br/><label>ISSN: </label>0927-3042 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Animals<br/>Antineoplastic Agents--adverse effects<br/>Bone Marrow Cells--drug effects<br/>Cell Division<br/>Cells, Cultured--pathology<br/>Chromosome Aberrations<br/>Chromosomes, Human--genetics<br/>Clone Cells--pathology<br/>Cytokines--physiology<br/>Disease Models, Animal<br/>Disease Progression<br/>Gene Expression Regulation, Leukemic<br/>Genes, Tumor Suppressor<br/>Genetic Predisposition to Disease<br/>Hematopoiesis<br/>Hematopoietic Stem Cell Transplantation<br/>Hematopoietic Stem Cells--drug effects<br/>Humans<br/>Leukemia, Myeloid--etiology<br/>Lymphoma--pathology<br/>Mice<br/>Mice, Transgenic<br/>Myelodysplastic Syndromes--genetics<br/>Myeloproliferative Disorders--pathology<br/>Neoplasms, Second Primary--etiology<br/>Oncogenes<br/>Preleukemia--genetics